Clinical Trial Update: Experimental Study to Validate the Modified Glucose Disposal Test [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial conducted by Bristol-Myers Squibb to validate a Modified Glucose Disposal Test for diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Diabetes | Phase 1 | Status: COMPLETED